0.2650
-0.0118
(-4.26%)
At close: January 10 at 4:00:01 PM EST
0.2587
-0.01
(-2.38%)
After hours: January 10 at 7:59:49 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-35,011.5890
-34,879.9030
-46,457.4880
-57,489.5300
-39,241.9310
Investing Cash Flow
-10.7730
-21.3940
-84.1910
-14.9430
-68.5070
Financing Cash Flow
6.3970
28,823.5080
4,157.4080
10,724.3460
18,144.0140
End Cash Position
14,391.6640
41,792.8300
47,870.6190
90,254.8900
137,035.0170
Capital Expenditure
-10.7730
-21.3940
-84.1910
-14.9430
-68.5070
Issuance of Capital Stock
--
28,707.0110
4,157.4080
10,699.3170
17,824.7170
Free Cash Flow
-35,022.3620
-34,901.2970
-46,541.6790
-57,504.4730
-39,310.4380
12/31/2020 - 1/10/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LYRA Lyra Therapeutics, Inc.
0.1955
-2.59%
GRI GRI Bio, Inc.
0.7625
+3.80%
GNPX Genprex, Inc.
0.7800
-3.26%
ENVB Enveric Biosciences, Inc.
0.4020
-3.34%
ADIL Adial Pharmaceuticals, Inc.
1.0200
-0.97%
OGEN Oragenics, Inc.
0.3430
+2.82%
GLMD Galmed Pharmaceuticals Ltd.
2.9000
-1.36%
SNSE Sensei Biotherapeutics, Inc.
0.5125
-3.30%
CARM Carisma Therapeutics, Inc.
0.4712
-0.61%
APLM Apollomics, Inc.
10.54
-1.68%